ARCHIVES

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 19 | May 9, 2003

Download PDF Visit The Full Archive

Related Articles

Undeterred By Randomized Trial Results, AUA Calls For Baseline PSA At Age 40.

May 1, 2009

Study Seeks Sisters Of Women With Breast Cancer

September 27, 2002

NCAB Committee Approved Concepts For D Contracts

December 7, 1984

NS Sponsors Workshop On Prevention For Three Minority Groups

July 1, 1988

BRCA Carriers Live Longer Than Those With Normal Gene

January 25, 2008

In Congress: Senate Committee Approves 15% Increase For NCI In FY 1999; Report Urges NCI To Increase Research In Several Cancers

September 11, 1998